Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Rojano, C. Calero, F. J. Saenz, M. López-Porras, E. Arellano, A. Blanco, J. L. Lopez-Campos (Seville, Spain). The Importance of the local expression of acute phase reactants in the COPD. Eur Respir J 2010; 36: Suppl. 54, 559

Member's Comments

No comment yet.

Related content which might interest you: Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients Year: 2021 Serum acute phase reactants in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002 The relations between levels of acute phase reactants and severity of community acquired pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 464s Year: 2001 Relation between level of acute phase proteins and efficiency of treatment in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006 Can acute phase proteins predict survival in ventilated patients with acute exacerbation of COPD? Source: Annual Congress 2012 - COPD exacerbation Year: 2012 The dynamics of reactants of acute phase of inflammation in adolescents with newly detected drug-resistant TB during the treatment Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents Year: 2008 Analysis of cytokine gene expression after treatment and pulmonary rehabilitation of acute exacerbation in COPD Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 The effectiveness of early pulmonary rehabilitation in acute exacerbation of COPD in the terms of functional and systemic markers. Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 Acute phase reactants as predictors for hospital mortality in acute respiratory failure due to COPD exacerbation Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Acute phase markers in elderly patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Time course of systemic inflammatory markers during acute exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007 Vascular-platelet hemostasis parameters in the stable phase and in acute exacerbation (AE) of COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Adiponectin as a biomarker of systemic inflammatory response in stable and exacerbation phases of COPD Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Characterisation of a model that mimics aspects of the hyper-inflammatory response observed during an acute exacerbation of COPD. Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 Changes in lung function in acute COPD Source: Eur Respir J 2003; 22: Suppl. 45, 239s Year: 2003 Prognostic impact of pleuropulmonary pathologies in the early phase of acute pancreatitis. Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases Year: 2021 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Local and systemic inflammation in acute viral exacerbations of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 251s Year: 2005